Show simple item record

Authordc.contributor.authorOyarzún Ampuero, Felipe 
Authordc.contributor.authorGuerrero Hernández, Ariel 
Authordc.contributor.authorHassan López, Natalia 
Authordc.contributor.authorMorales Valenzuela, Javier 
Authordc.contributor.authorBollo Dragnic, Soledad 
Authordc.contributor.authorCorvalán Rodríguez, Alejandro 
Authordc.contributor.authorQuest, Andrew F. G. 
Authordc.contributor.authorKogan Bocian, Marcelo 
Admission datedc.date.accessioned2015-12-23T01:26:33Z
Available datedc.date.available2015-12-23T01:26:33Z
Publication datedc.date.issued2015
Cita de ítemdc.identifier.citationCurrent Pharmaceutical Design Volumen: 21 Número: 29 (2015)en_US
Identifierdc.identifier.issn1381-6128
Identifierdc.identifier.otherDOI: 10.2174/1381612821666150901095538
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/135914
General notedc.descriptionArtículo de publicación ISIen_US
General notedc.descriptionSin acceso a texto completo
Abstractdc.description.abstractOrganic and inorganic nanoparticles show great potential for cancer diagnosis and treatment. Because gastric cancer (GC) represents the second most deadly type of neoplasia worldwide, continued research efforts by scientists and clinicians are essential to improve diagnosis and treatment. This paper reviews significant findings in the area of nanoparticles (organic and inorganic origin) that may aid in prevention and diagnosis of GC. This review focuses in the first section on H. pylori and the connection to GC, highlighting nanoformulations designed to control bacterial growth. The second section evaluates the potential of different imaging techniques (especially using inorganic nanoparticles) in the detection of GC, and the third section summarizes how nanotechnology may be employed in the analytical detection of GC biomarkers (metallic plasmons, electrochemical biosensors and colorimetric sensors). We foresee that the prevention and diagnosis of GC will require the development of complex collaborative studies. Additionally, scientists also need to be tightly connected to industry in order to facilitate upscaling and rapid transfer of promising products to the clinicen_US
Patrocinadordc.description.sponsorshipFondecyt 11121481 1130425 3150360 3140489 1111014 1130250 11130235 Ring grant 1111en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherBenthamen_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectNanocarriersen_US
Keywordsdc.subjectBiomarkersen_US
Keywordsdc.subjectDrug deliveryen_US
Keywordsdc.subjectHelicobacter pylorien_US
Keywordsdc.subjectGastric canceren_US
Keywordsdc.subjectEpigeneticen_US
Títulodc.titleOrganic and Inorganic Nanoparticles for Prevention and Diagnosis of Gastric Canceren_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile